Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):1178–1181. doi: 10.1128/aac.41.5.1178

Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing.

D M Bamberger 1, B L Herndon 1, M Dew 1, R P Chern 1, H Mitchell 1, L E Summers 1, R F Marcus 1, S C Kim 1, P R Suvarna 1
PMCID: PMC163877  PMID: 9145896

Abstract

We studied the efficacies of ofloxacin, rifampin, and clindamycin in a Staphylococcus aureus abscess model and seven antimicrobial regimens in an intracellular killing assay. Ofloxacin plus rifampin was the most effective regimen in the abscess model, and rifampin and ofloxacin were the most active regimens in the intracellular killing assay.

Full Text

The Full Text of this article is available as a PDF (244.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamberger D. M., Fields M. T., Herndon B. L. Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing. Antimicrob Agents Chemother. 1991 Nov;35(11):2335–2339. doi: 10.1128/aac.35.11.2335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bamberger D. M., Herndon B. L. Bactericidal capacity of neutrophils in rabbits with experimental acute and chronic abscesses. J Infect Dis. 1990 Jul;162(1):186–192. doi: 10.1093/infdis/162.1.186. [DOI] [PubMed] [Google Scholar]
  3. Bamberger D. M., Herndon B. L., Suvarna P. R. Azithromycin in an experimental Staphylococcus aureus abscess model. J Antimicrob Chemother. 1995 May;35(5):623–629. doi: 10.1093/jac/35.5.623. [DOI] [PubMed] [Google Scholar]
  4. Barza M. Challenges to antibiotic activity in tissue. Clin Infect Dis. 1994 Nov;19(5):910–915. doi: 10.1093/clinids/19.5.910. [DOI] [PubMed] [Google Scholar]
  5. Beam T. R., Jr Sequestration of staphylococci at an inaccessible focus. Lancet. 1979 Aug 4;2(8136):227–228. doi: 10.1016/s0140-6736(79)90239-3. [DOI] [PubMed] [Google Scholar]
  6. Buggy B. P., Schaberg D. R., Swartz R. D. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med. 1984 Jun;76(6):1035–1040. doi: 10.1016/0002-9343(84)90854-4. [DOI] [PubMed] [Google Scholar]
  7. Gemmell C. G. Antibiotics and the expression of staphylococcal virulence. J Antimicrob Chemother. 1995 Aug;36(2):283–291. doi: 10.1093/jac/36.2.283. [DOI] [PubMed] [Google Scholar]
  8. Hand W. L., King-Thompson N. L. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob Agents Chemother. 1986 Jan;29(1):135–140. doi: 10.1128/aac.29.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jacobs R. F., Wilson C. B. Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):13–20. doi: 10.1093/jac/12.suppl_c.13. [DOI] [PubMed] [Google Scholar]
  10. Mandell G. L., Vest T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis. 1972 May;125(5):486–490. doi: 10.1093/infdis/125.5.486. [DOI] [PubMed] [Google Scholar]
  11. Norden C. W. Lessons learned from animal models of osteomyelitis. Rev Infect Dis. 1988 Jan-Feb;10(1):103–110. doi: 10.1093/clinids/10.1.103. [DOI] [PubMed] [Google Scholar]
  12. Proctor R. A., Hamill R. J., Mosher D. F., Textor J. A., Olbrantz P. J. Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):85–95. doi: 10.1093/jac/12.suppl_c.85. [DOI] [PubMed] [Google Scholar]
  13. Sanchez M. S., Ford C. W., Yancey R. J., Jr Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage. J Antimicrob Chemother. 1988 Jun;21(6):773–786. doi: 10.1093/jac/21.6.773. [DOI] [PubMed] [Google Scholar]
  14. Stevens D. L., Yan S., Bryant A. E. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993 Jun;167(6):1401–1405. doi: 10.1093/infdis/167.6.1401. [DOI] [PubMed] [Google Scholar]
  15. Swanberg L., Tuazon C. U. Rifampin in the treatment of serious staphylococcal infections. Am J Med Sci. 1984 May-Jun;287(3):49–54. doi: 10.1097/00000441-198405000-00018. [DOI] [PubMed] [Google Scholar]
  16. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Van der Auwera P., Prinz G., Petrikkos G. Activity of intracellular antibiotics. Infection. 1991;19 (Suppl 4):S216–S223. doi: 10.1007/BF01644037. [DOI] [PubMed] [Google Scholar]
  18. Zimmerli W., Frei R., Widmer A. F., Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994 May;33(5):959–967. doi: 10.1093/jac/33.5.959. [DOI] [PubMed] [Google Scholar]
  19. van den Broek P. J. Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis. 1989 Mar-Apr;11(2):213–245. doi: 10.1093/clinids/11.2.213. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES